Press Room
The Canadian pharmaceutical company Duchesnay Inc. sets for international expansion following the US approval of its morning sickness medication Diclegis by the FDA
Duchesnay Inc. and Tzamal Medical Group Ltd Sign an Agreement for the Drug Diclectin® for the Management of Nausea and Vomiting of Pregnancy
Duchesnay contributes $25,000 to the Wabano Mamawi Aboriginal Health Care Center located in Vanier
PregVit® and PregVit folic 5® Prenatal Multivitamins: Confirmed Fully Compliant with Passover Requirements
Prevegyne™: A new Solution for the Treatment and Prevention of Bacterial Vaginosis Now Available in Canada
A Safe and Effective Drug for Morning Sickness- A Large New American Study Reports
